Natures Sunshine Products Inc
NATR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000275053
In the last 90 days, Natures Sunshine Products Inc insiders filed 2 open-market purchases and 0 sales; 153 institutions reported holding it in 13F filings for Q2 2026, worth $343.6M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:05 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 10, 2026 | – | Mar 12, 2024 | Mar 16, 2023 | – |
| Revenue | $480.1M | $454.4M | $445.3M | $421.9M | $444.1M |
| Cost of revenue | $132.4M | $129.7M | $124.2M | $122.2M | $115.5M |
| Gross profit | $347.7M | $324.7M | $321.1M | $299.8M | $328.6M |
| Research and development | $1.90M | $1.70M | $1.60M | $1.50M | $1.40M |
| Selling, general and administrative | $178.4M | $164.0M | $167.1M | $153.1M | $154.1M |
| Operating income | $24.7M | $20.1M | $18.7M | $16.3M | $34.7M |
| Interest expense | – | – | $69.0K | $249.0K | $250.0K |
| Income tax | $9.36M | $10.5M | $3.79M | $14.7M | $1.61M |
| Net income | $19.5M | $7.70M | $15.1M | $550.0K | $30.2M |
| EPS, basic | $1.08 | $0.41 | $0.79 | $-0.02 | $1.45 |
| EPS, diluted | $1.06 | $0.40 | $0.77 | $-0.02 | $1.42 |
| Weighted shares, basic | 18.0M | 18.6M | 19.1M | 19.3M | 19.9M |
| Weighted shares, diluted | 18.5M | 19.1M | 19.5M | 19.3M | 20.3M |
| Margins and growth | |||||
| Gross margin | 72.4% | 71.5% | 72.1% | 71.0% | 74.0% |
| Operating margin | 5.2% | 4.4% | 4.2% | 3.9% | 7.8% |
| Net margin | 4.1% | 1.7% | 3.4% | 0.1% | 6.8% |
| Revenue growth, year over year | +5.7% | +2.0% | +5.5% | −5.0% | +15.3% |
| Net income growth, year over year | +153.7% | −49.0% | +2,641.1% | −98.2% | +31.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 10, 2026 | – | Mar 12, 2024 | Mar 16, 2023 | – |
| Cash and equivalents | $93.9M | $84.7M | $82.4M | $60.0M | $86.2M |
| Accounts receivable | $8.60M | $9.48M | $8.83M | $14.1M | $8.87M |
| Inventory | $68.3M | $59.4M | $66.9M | $67.9M | $60.9M |
| Total current assets | $178.8M | $160.6M | $165.8M | $149.5M | $164.7M |
| Property, plant and equipment | $32.9M | $39.6M | $45.0M | $46.2M | $50.9M |
| Total assets | $261.1M | $240.9M | $249.8M | $229.8M | $258.9M |
| Accounts payable | $8.02M | $8.91M | $7.91M | $6.35M | $9.70M |
| Short-term debt | – | – | $0 | $1.17M | $1.24M |
| Total current liabilities | $78.5M | $65.7M | $76.8M | $65.6M | $76.7M |
| Long-term debt | – | – | – | $0 | $1.17M |
| Total liabilities | $99.6M | $79.9M | $90.2M | $82.7M | $97.5M |
| Shareholders' equity | $161.6M | $161.0M | $159.5M | $147.0M | $161.4M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 10, 2026 | – | Mar 12, 2024 | Mar 16, 2023 | – |
| Operating cash flow | $35.3M | $25.3M | $41.2M | $710.0K | $34.6M |
| Capital expenditures | $6.48M | $11.0M | $10.5M | $7.63M | $6.67M |
| Free cash flow | $28.8M | $14.3M | $30.7M | -$6.92M | $27.9M |
| Depreciation and amortization | $13.8M | $14.2M | $11.8M | $11.0M | $11.2M |
| Stock-based compensation | $5.78M | $4.79M | $4.89M | $2.90M | $3.73M |
| Dividends paid | – | – | – | $0 | $19.9M |
| Share buybacks | $16.3M | $8.86M | $6.40M | $13.6M | $7.42M |
| Investing cash flow | -$6.48M | -$11.0M | -$10.5M | -$7.63M | -$6.61M |
| Financing cash flow | -$23.8M | -$9.90M | -$7.96M | -$16.2M | -$31.7M |
| Net change in cash | $9.19M | $2.33M | $22.3M | -$26.2M | -$5.88M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.2% | 1.1% | 1.1% | 0.7% | 0.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 23, 2026 | 17.3M | −1.0% | SEC |
| Jul 24, 2026 | 17.6M | −0.2% | SEC |
| Apr 24, 2026 | 17.6M | −4.2% | SEC |
| Feb 20, 2026 | 17.5M | −5.3% | SEC |
| Oct 24, 2025 | 17.5M | −5.3% | SEC |
| Jul 18, 2025 | 17.6M | −4.7% | SEC |
| Apr 18, 2025 | 18.4M | −2.0% | SEC |
| Feb 21, 2025 | 18.5M | −1.8% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.